First Page | Document Content | |
---|---|---|
Leukotriene antagonists Pharmacology Organochlorides Respiratory therapy Drug safety Montelukast Churg–Strauss syndrome Merck & Co. Allergy Medicine Health Pulmonology | Department of Health and Human ServicesAdd to Reading ListSource URL: www.fda.govDownload Document from Source WebsiteFile Size: 534,34 KBShare Document on Facebook |
DEVELOPMENT OF PHARMACEUTICAL PRODUCTS UTILIZING EXTRUSION TECHNOLOGIES Graciela Terife Senior Scientist, Product Value Enhancement Merck & Co., Summit, NJDocID: 1nXt9 - View Document | |
Title: font: times; size: 18 point; style: plain; justified: center; capitalization: first word and Names only THE CHALLENGE OF DEVELOPING AN MMRVVV COMBINATION VACCINE Alan R. Shaw, PhDDocID: 1gGkP - View Document | |
Your contact News Release Gangolf SchrimpfDocID: 1aWSz - View Document | |
TRUSOPT Ped data PARDocID: 1aNXe - View Document | |
CNODES: A Canadian Initiative Samy Suissa Lady Davis Institute, Jewish General Hospital McGill University Montreal, CanadaDocID: 1aAtH - View Document |